References
- Heidari R, Sadeghi M, Talaei M, Rabiei K, Mohammadifard N, Sarrafzadegan N. Metabolic syndrome in menopausal transition: isfahan healthy heart program, a population based study. Diabetol Metab Syndr 2010;2:59
- Jouyandeh Z, Nayebzadeh F, Qorbani M, Asadi M. Metabolic syndrome and menopause. J Diabetes Metab Disord 2013;12:1
- Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113–32
- Wassink AM, van der Graaf Y, Olijhoek JK, Visseren FL. Smart Study Group. Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2008;29:213–23
- Park JS, Kang S, Ahn CW, Cha BS, Kim KR, Lee HC. Relationships between serum uric acid, adiponectin and arterial stiffness in postmenopausal women. Maturitas 2012;73:344–8
- Ioannou GN, Boyko EJ. Effects of menopause and hormone replacement therapy on the associations of hyperuricemia with mortality. Atherosclerosis 2013;226:220–7
- Koga M, Saito H, Mukai M, Kasayama S, Yamamoto T. Factors contributing to increased serum urate in postmenopausal Japanese females. Climacteric 2009;12:146–52
- Hak AE, Choi HK. Menopause, postmenopausal hormone use and serum uric acid levels in US women–the third national health and nutrition examination survey. Arthritis Res Ther 2008;10:R116
- Gibson CJ, Thurston RC, El Khoudary SR, Sutton-Tyrrell K, Matthews KA. Body mass index following natural menopause and hysterectomy with and without bilateral oophorectomy. Int J Obes 2013;37:809–13
- Hong SP, Lee YS, Bae KR, et al. Relationship between serum uric acid level and metabolic syndrome according to gender. Korean Circ J 2008;38:152–60
- Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2008;42:1183–90
- Manttari M, Tutula E, Alikkoski T, Manninen V. Effect of hypertension and dyslipidemia on the decline in renal function. Hypertension 1995;26:670–5
- Chen HS. Clinical implications of the metabolic syndrome and hyperuricemia. J Chin Med Assoc 2011;74:527–8
- Lee HJ, Park HT, Cho GJ, et al. Relationship between uric acid and metabolic syndrome according to menopausal status. Gynecol Endocrinol 2011;27:406–11
- Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007;120:442–7
- Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages of reproductive aging workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric 2012;15:105–14
- Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation 2005;112:2735–52
- Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the national health and nutrition examination survey 2007-2008. Arthritis Rheum 2011;63:3136–41
- Krishnan E, Bennette M, Chen L. Aging, not menopause, is associated with higher prevalence of hyperuricemia among older women. Menopause 2014;21:1211–16
- Dincer HE, Dincer AP, Levinson DJ. Asymptomatic hyperuricemia: to treat or not to treat. Cleve Clin J Med 2002;69:594, 597, 600–2
- Kuo C, Grainage MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 2015;11:649–62
- Guan S, Tang Z, Fang X, et al. Prevalence of hyperuricemia among Beijing post-menopausal women in 10 years. Arch Gerontol Geriatr 2016;64:162–6
- Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000;283:2404–10
- Liu PJ, MA F, Lou HP, Zhu YN, Chen Y. Relationship between serum uric acid levels and metabolic syndrome in Chinese postmenopausal women. Climacteric 2014;17:148–54
- Aekplakorn W, Abbott-Klafter J, Premgamone A, et al. Prevalence and management of diabetes and associated risk factors by regions of Thailand: third national health examination survey 2004. Diabetes Care 2007;30:2007–12
- Aekplakorn W, Chariyalertsak S, Kessomboon P, et al. Prevalence and management of diabetes and metabolic risk factors in Thai adults: the Thai National Health Examination Survey IV, 2009. Diabetes Care 2011;34:1980–5
- Indhavivadhana S, Rattanachaiyanont M, Wongvananurak T, et al. Predictors for metabolic syndrome in perimenopausal and postmenopausal Thai women. Climacteric 2011;14:58–65
- Dorum A, Tonstad S, Liavaag AH, Michelson TM, Hindrum R, Dahl A. Bilateral oophorectomy before 50 years of age is significantly associated with metabolic syndrome and framingham risk score: a controlled, population-based study (HUNT-2). Gynecol Oncol 2008;109:377–83
- Gravena AA, Brischiliari SC, Lopes TC, Agnolo CM, Carvalho MD, Pelloso SM. Excess weight and abdominal obesity in postmenopausal Brazilian women: a population-based study. BMC Womens Health 2013;13:46
- Al-Safi ZA, Polotsky AJ. Obesity and menopause. Best Pract Res Clin Obstet Gynaecol 2015;29:548–53
- Maruhashi T, Nakashima A, Soga J, et al. Hyperuricemia is independently associated with endothelial dysfunction in postmenopausal women but not in premenopausal women. BMJ Open 2013;3:e003659